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analysis for MTNR1B receptor SNP, rs10830963, as part of a larger
study. Using a validated method, CHART-DEL, all charts were reviewed
and scored for the likelihood of delirium without knowledge of the results
of the MTNR1B gene polymorphism. CHART-DEL has a sensitivity of
74%, specificity of 83%.5,6 It was decided a priori patients rated as
probable and definite delirium would be categorized as having delirium.
The Fisher exact was used for analysis.
Results: Genotyping for the MTNR1B gene was acceptable in 80 subjects
of which 18 (22.5%) had delirium. Four (57.1%) of patients with the risk
genotype had delirium versus only 14 (19.2%) without the genotype,
P= 0.04.
Conclusions: Although our study was limited to cardiac surgery, has
relatively small sample size, and retrospectively assessed for the pres-
ence of delirium, the significant correlation of the risk geno-
type of the MTNR1B melatonin receptor with delirium is intriguing and
warrants further prospective studies. Our data supports a role for the
MTNR1B melatonin receptor in the pathogenesis of postoperative
delirium.
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[SNACC-48] The Impact of Hypotension During Stroke Inter-
vention May Depend on Type of Anesthesia and Stroke Severity
Tang L, Whalin M. Emory University School of Medicine, Atlanta, GA.
Introduction: Recent studies have linked intraprocedural hypotension to
poor neurological outcomes in stroke patients receiving thrombectomies
under both monitored anesthetic care (MAC)1 and general anesthesia
(GA).2 The GA study included only 60 patients so those authors were
unable to examine blood pressure thresholds for GA patients. We hy-
pothesized that decreases in MAP would have a similar effect in patients
whether they received MAC or GA.
Methods: We retrospectively examined patients who were successfully
reperfused (modified thrombolysis in cerebral infarction scores of 2b or 3)
at our institution from 2010 until 2015. We identified 439 such patients
with complete anesthetic, hemodynamic, and outcome data. Percentage
MAP drop was defined based on the change from baseline to the lowest
recorded MAP before mTICI 2b/3 reperfusion. Stroke severity was based
on the admission NIH stroke scale (NIHSS) score. Good outcome was
defined as a modified Rankin score (mRS) at 90 days of 0 to 2, which
corresponds to functional independence.
Results: In our cohort the rate of good outcome was 58% in the 297
patients who received MAC and 39% in the 142 patients who received
GA. MAP fell more than 20% from baseline in 62% of MAC cases and
84% of GA cases. As shown in the figure, in patients with strokes of
intermediate severity (NIHSS 16 to 20) keeping MAP within 10% of
baseline was associated with substantially more good outcomes for both
GA and MAC patients. In those with severe strokes (NIHSS> 20) tight
hemodynamic control appeared to have a smaller impact on outcome for
both anesthetic groups. For less severe strokes (NIHSS< 16) hypotension
appeared to have a more profound impact for GA patients than for MAC
patients.
Conclusions: Maintaining MAP within 10% of baseline was associated
with higher rates of good outcome in all subgroups studied. Our analysis
was limited by the small proportion of patients who maintained MAP
within 10% of baseline, especially in the GA group. However, such tight
hemodynamic control seemed to be particularly beneficial to all patients
with NIHSS 16 to 20 and patients with NIHSS< 16 who received GA.
Anesthesiologists should try to maintain MAP within 10% of baseline
values for both MAC and GA cases.
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Background: The importance of personalized medicine is becoming
increasingly recognized in anesthesia. Titration of the different drugs
used in anesthesiology has become possible due to monitors that allow
us to measure the different effects. However, regarding the analgesic
effect, there are not many available solutions yet. The Pupillary Reflex
Dilation has been studied as a surrogate for measuring the nociception/
antinociception balance of patients, both in the operating theater as
well as in intensive care.1 The aim of this study was to assess the
Pupillary Pain Index (PPI) association with different concentrations of
remifentanil.
Methods: This was an observational prospective study, where 34 con-
secutive patients were enrolled. Patients scheduled for neurosurgical
procedures, with general TIVA anesthesia with propofol and remifentanil
were considered when no premedication was used. Induction began with
an infusion of remifentanil targeted for a constant concentration using
Minto PK Model and then an infusion of propofol at 200mL/h was
started until loss of consciousness was observed. Afterwards, an infrared
portable pupillometer (AlgiScan—IDMed, France) was used to assess the
Pupillary Dilation Reflex and its derived index PPI. Following this
measurement, remifentanil concentrations could be increased or de-
creased if deemed necessary by the anesthesiologist. The PPI consists in
measuring the pupillary dilation in response to a continuously increasing
electric stimulus discharge, that stops when > 13% dilation from baseline
is achieved, or when 60mA is reached. PPI measurements were taken
after loss of consciousness and before surgery, at moments when no other
stimulus were present. For each measure of PPI the predicted effect-site
concentration (EC) of remifentanil (Minto PK model) and of propofol
(Schnider PK Model); and the BIS value were noted. Data are mean±
SD or %.
Results: A total of 78 measures of PPI were done. Patients’ data were:
57± 15 years; 73± 21 kg; 162±8 cm; 60% female; 11.5% ASA I; 80.8%
ASA II; Remifentanil EC 2.4± 1.5 ng/mL; propofol EC 3.7± 1.3 ug/mL;
BIS 46.1± 8.2; PPI 4.8 ± 3. A correlation was observed between the re-
mifentanil EC and PPI (R=−0.46, P< 0.001), but not between PPI and
propofol EC or BIS. A correlation was observed between BIS and pro-
pofol CE (R=−0.26, P= 0.028), but not with remifentanil. Tukey HSD
test showed that the different is mainly due to concentrations <3 versus
≥ 3 ng/mL.
Conclusions: We found a significant correlation between the remifentanil
concentration and PPI, showing that PPI discriminates different levels of
analgesia. No correlation was found with propofol or BIS. However,
there was no clear discrimination between all levels of remifentanil con-
centrations analyzed. Further research should be done, with more data
and more stratified levels of remifentanil.
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[SNACC-50] Analgesic Interpatient Variability of Remifentanil
Assessed Through Pupillary Dilation Reflex
Vide S*, Correia R†, Nunes C‡, Amorim P†. *Hospital Pedro Hispano,
Matosinhos. †Centro Hospitalar Do Porto. ‡Universidade Aberta, Porto,
Portugal.
Background: Although there has been significant focus on unconsciousness
and amnesia, identifying the neural signatures of effective analgesia has re-
ceived less attention.1 Currently, appraisal of intraoperative nociception is
mostly done through the assessment of the autonomic response to noxious
stimuli, whether it is through heart rate variability, heartbeat intervals, ple-
thysmographic pulse wave amplitude, skin conductance or pupillary re-
sponse.2 The known wide inter-patient variability of the hypnotic effect,
namely in the amount of propofol needed to achieve loss of consciousness, led
us to question if this variability also happened for the analgesic effect. In this
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